Metraipolis › archive › dc_bac6abc8fc88
Serum GFAP and NfL augment a metabolomics-driven strategy for long-term prediction of multiple sclerosis progression — Europe PMC PMID:41741703
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41741703
- DOI
- 10.1038/s43856-[numero omesso]-5
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-05T08:08:38.397Z
- SHA-256 of the archived text
8163fb8864bf8cdd1648a8d0e849c059e9caba868fe390eacc92438987bed321- Stable URL of this page
https://metraipolis.com/documento/dc_bac6abc8fc88
How to cite
Serum GFAP and NfL augment a metabolomics-driven strategy for long-term prediction of multiple sclerosis progression — Europe PMC PMID:41741703 — Europe PMC (en), https://europepmc.org/article/MED/41741703 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_bac6abc8fc88 (Metraipolis archive dc_bac6abc8fc88, sha256 8163fb8864bf8cdd1648a8d0e849c059e9caba868fe390eacc92438987bed321)
BibTeX
@misc{dcbac6abc8fc88,
title = {Serum GFAP and NfL augment a metabolomics-driven strategy for long-term prediction of multiple sclerosis progression — Europe PMC PMID:41741703},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41741703},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_bac6abc8fc88; sha256 8163fb8864bf8cdd1648a8d0e849c059e9caba868fe390eacc92438987bed321},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41741703. Agents can read the archived copy with the MCP tool read_document.